Quantitative Structure Analysis of Some Molecules in Drugs Used in the Treatment of COVID-19 with Topological Indices

被引:30
|
作者
Havare, Ozge Colakoglu [1 ]
机构
[1] Mersin Univ, Arts & Sci Fac, Dept Math, TR-33343 Mersin, Turkey
关键词
Antiviral; drugs; QSPR; GRAPH-THEORY; PREDICTION; QSPR;
D O I
10.1080/10406638.2021.1934045
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
COVID-19 is a disease caused by the new coronavirus, which has been spreading rapidly all over the world. There is no exact drug yet for the treatment of COVID-19 disease, and its treatment is tried to be provided with existing drugs. However, new drug research is being carried out to treat this disease. Topological indices are numerical descriptors based on the molecular graph of the molecular structure. Topological indices are used in modeling to predict the physicochemical properties and biological activities of molecules in the quantitative structure-property relationship (QSPR), quantitative structure-activity relationship (QSAR) studies. In this study, remdesivir, chloroquine, hydroxychloroquine, theaflavin, thalidomide, arbidol, lopinavir, ritonavir drugs used in the treatment of COVID-19 patients are studied. The QSPR model is designed using some degree-based indices, Mostar-type indices, and distance-based topological indices to predict the various physicochemical properties of these drugs. The relationship analyses between the physicochemical properties and the topological indices in the QSPR model are done by using the curvilinear regression method.
引用
收藏
页码:5249 / 5260
页数:12
相关论文
共 50 条
  • [41] Development of RP-HPLC methods for the analysis of Dexamethasone and Levofloxacin alone and in combinations used in the therapy of Covid-19
    Peikova, Lily
    Tzankova, Diana
    Smerikarova, Miglena
    Balkanski, Stefan
    Zlatkov, Alexander
    PHARMACIA, 2022, 69 (04) : 1075 - 1080
  • [42] Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off-label in the first wave of COVID-19
    Delaunois, Annie
    Abernathy, Matthew
    Anderson, Warren D.
    Beattie, Kylie A.
    Chaudhary, Khuram W.
    Coulot, Julie
    Gryshkova, Vitalina
    Hebeisen, Simon
    Holbrook, Mark
    Kramer, James
    Kuryshev, Yuri
    Leishman, Derek
    Lushbough, Isabel
    Passini, Elisa
    Redfern, Will S.
    Rodriguez, Blanca
    Rossman, Eric I.
    Trovato, Cristian
    Wu, Caiyun
    Valentin, Jean-Pierre
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (03): : 1133 - 1146
  • [43] Traditional Chinese medicine practices used in COVID-19 (Sars-cov 2/Coronavirus-19) treatment in clinic and their effects on the cardiovascular system
    Akalin, Emine
    Ekici, Mirac
    Alan, Zinar
    Elevli, Elif Ozbir
    Bucak, Aysenur Yaman
    Aobuliaikemu, Nuerbiye
    Uresin, Ali Yagiz
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2020, 48 (04): : 410 - 424
  • [44] Network pharmacology and molecular docking analysis on mechanisms of Tibetan Hongjingtian (Rhodiola crenulata) in the treatment of COVID-19
    Wang, Li
    Wang, Yuhe
    Yang, Wei
    He, Xue
    Xu, Shilin
    Liu, Xiaoli
    He, Yongjun
    Hu, Qunying
    Yuan, Dongya
    Jin, Tianbo
    JOURNAL OF MEDICAL MICROBIOLOGY, 2021, 70 (07)
  • [45] Serial viral load analysis by DDPCR to evaluate FNC efficacy and safety in the treatment of mild cases of COVID-19
    da Silva, Renato Martins
    Cabral, Paula Gebe Abreu
    de Souza, Savio Bastos
    Arruda, Raul Ferraz
    Cabral, Sheila Passos de Figueiredo
    de Assis, Aricia Leone Evangelista Monteiro
    Martins, Yolanda Porto Muniz
    Tavares, Carlos Augusto de Araujo
    Viana Junior, Antonio Brazil
    Chang, Junbiao
    Lei, Pingsheng
    FRONTIERS IN MEDICINE, 2023, 10
  • [46] Efficacy of lopinavir-ritonavir combination therapy for the treatment of hospitalized COVID-19 patients: a meta-analysis
    Deng, Jiawen
    Zhou, Fangwen
    Houl, Wenteng
    Heybati, Kiyan
    Ali, Saif
    Chang, Oswin
    Silver, Zachary
    Dhivagaran, Thanansayan
    Ramaraju, Harikrishnaa Ba
    Wong, Chi Yi
    Zuo, Qi Kang
    Lapshina, Elizabeth
    Mellett, Madeline
    FUTURE VIROLOGY, 2022, 17 (03) : 169 - 189
  • [47] Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19
    Tao, Quyuan
    Du, Jiaxin
    Li, Xiantao
    Zeng, Jingyan
    Tan, Bo
    Xu, Jianhua
    Lin, Wenjia
    Chen, Xin-lin
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2020, 46 (08) : 1345 - 1353
  • [48] How New Mexico Leveraged a COVID-19 Case Forecasting Model to Preemptively Address the Health Care Needs of the State: Quantitative Analysis
    Castro, Lauren A.
    Shelley, Courtney D.
    Osthus, Dave
    Michaud, Isaac
    Mitchell, Jason
    Manore, Carrie A.
    Del Valle, Sara Y.
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2021, 7 (06):
  • [49] Effects of four types of integrated Chinese and Western medicines for the treatment of COVID-19 in China: a network meta-analysis
    Jin, Lairun
    Xu, Yan
    Yuan, Hui
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (06): : 771 - 777
  • [50] Towards the discovery of potential RdRp inhibitors for the treatment of COVID-19: structure guided virtual screening, computational ADME and molecular dynamics study
    Aftab Alam
    Gopal Prasad Agrawal
    Shamshir Khan
    Habibullah Khalilullah
    Muhammed Khalid Saifullah
    Mohammed Faiz Arshad
    Structural Chemistry, 2022, 33 : 1569 - 1583